Skip to content
Inciteful Med

Diagnosis and Understanding Your Test Results

Last updated:

Hereditary Elliptocytosis (HE) is diagnosed using a peripheral blood smear to look for oval-shaped red blood cells. Doctors also use osmotic gradient ektacytometry to test cell flexibility and genetic testing to find specific mutations in the SPTA1, SPTB, or EPB41 genes.

Key Takeaways

  • • A peripheral blood smear is the primary test for HE, revealing oval or rod-shaped red blood cells instead of normal round cells.
  • • Severe forms like Hereditary Pyropoikilocytosis (HPP) will show fragmented cells and small round cells alongside elliptocytes.
  • • Osmotic gradient ektacytometry measures red blood cell flexibility and produces a unique trapezoidal curve in HE patients.
  • • The EMA binding test can produce misleading results in HE patients, sometimes leading to a misdiagnosis of Hereditary Spherocytosis.
  • • Next-Generation Sequencing (NGS) is the definitive genetic test, checking for mutations in the SPTA1, SPTB, or EPB41 genes.

The process of diagnosing Hereditary Elliptocytosis (HE) often involves a sequence of tests, moving from simple visual checks of your blood to high-tech genetic analysis [1][2]. Because HE can look very similar to other blood conditions, doctors use several specialized tools to confirm the diagnosis and determine its severity [3][4].

The Starting Point: Peripheral Blood Smear

The first and most important step is often a peripheral blood smear [5][6]. A laboratory specialist places a drop of your blood on a glass slide and looks at it under a microscope to see the shape of your red blood cells.

  • In Common HE: You will see a high percentage of elliptocytes—cells that are oval or rod-shaped instead of round [7][8]. The clinical threshold for HE usually requires more than 15–25% of the red blood cells to be elliptical [9][8].
  • In Severe Form (HPP): The view is more complex. Along with elliptocytes, there are often fragments of cells and small, round cells called spherocytes [4][10]. These fragmented cells look remarkably similar to the damage seen in patients with severe thermal burns, which is a hallmark of Hereditary Pyropoikilocytosis (HPP) [11].

Measuring Flexibility: Osmotic Gradient Ektacytometry (OGE)

Because the core problem in HE is a lack of flexibility, doctors may use a specialized test called Osmotic Gradient Ektacytometry (also known as an Osmoscan) [12][13].

This test measures how much your red blood cells can stretch when put under stress. In HE, this test produces a very specific “trapezoidal curve” [13][14]. This unique shape helps doctors distinguish HE from other conditions like Hereditary Spherocytosis (HS), which produces a different pattern on the scan [13].

Why the EMA Binding Test Can Be Misleading

You might hear about a test called EMA binding (Eosin-5-Maleimide). While this is a common and excellent screening tool for Hereditary Spherocytosis, it is not always reliable for HE [14][15].

The EMA test measures a specific protein on the cell surface. In some people with HE or HPP, the test results may come back low, which could lead a doctor to mistakenly diagnose them with Spherocytosis instead of Elliptocytosis [14][15]. This is why seeing the cell shapes under a microscope is so critical.

The Modern Gold Standard: Genetic Testing (NGS)

Today, Next-Generation Sequencing (NGS) is becoming the definitive way to diagnose HE [16][17]. This test looks directly at your DNA to find mutations in the three main genes known to cause the condition: SPTA1, SPTB, or EPB41 [3][18].

Genetic testing is particularly helpful because:

  • It clarifies severity: It can tell if you have one mutation (monoallelic), usually leading to mild HE, or two mutations (biallelic), which often leads to the more severe HPP [19][20].
  • It aids family planning: Knowing the exact mutation helps other family members get tested and provides clarity for parents about the risk of passing the condition to their children [21][2].
  • Setting Expectations: While highly accurate, genetic testing does not always provide a perfect answer. Sometimes, the test may find a “Variant of Uncertain Significance” (VUS), meaning a change in the gene was found, but it’s unclear if it’s the cause of the disease [2].

Genetic Counseling: If you are offered genetic testing, speaking with a Genetic Counselor is highly recommended. They can help you understand what the results mean for you and your family, and discuss options for family planning.

Frequently Asked Questions

How is Hereditary Elliptocytosis diagnosed on a blood smear?
A peripheral blood smear is the most important first step in diagnosing HE. A laboratory specialist examines your blood under a microscope to see if more than 15 to 25 percent of your red blood cells are shaped like ovals or rods instead of normal round circles.
What is an osmotic gradient ektacytometry test?
This test measures how much your red blood cells can stretch and bend when put under stress. In HE, the test produces a specific 'trapezoidal' pattern that helps doctors distinguish it from other blood cell disorders like Hereditary Spherocytosis.
Why is the EMA binding test not always reliable for diagnosing HE?
While the EMA test is excellent for diagnosing a similar condition called Hereditary Spherocytosis, it can give misleading low results for HE. This could lead a doctor to mistakenly diagnose you with the wrong blood disorder if they don't also check your cell shapes under a microscope.
What genes cause Hereditary Elliptocytosis?
Genetic testing looks directly at your DNA for mutations in three main genes: SPTA1, SPTB, or EPB41. Identifying your exact mutation helps determine the severity of your condition and provides important information for family planning.

Questions for Your Doctor

  • • What percentage of my red blood cells were elliptical on the blood smear?
  • • Did the blood smear show fragmented cells, which might suggest a more severe form like HPP?
  • • Is Osmotic Gradient Ektacytometry available to help confirm the 'trapezoidal' pattern common in HE?
  • • Why might the EMA binding test not be the best choice for diagnosing my specific condition?
  • • Can we use Next-Generation Sequencing (NGS) to find the exact gene mutation (SPTA1, SPTB, or EPB41) causing my HE?

Questions for You

  • • Has anyone else in my family been diagnosed with anemia or had their gallbladder removed at a young age?
  • • Am I experiencing symptoms like fatigue, jaundice, or abdominal pain that I should track?
  • • Am I comfortable with the idea of genetic testing to get a definitive answer about my condition?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Advances in laboratory diagnosis of hereditary spherocytosis.

    Farias MG

    Clinical chemistry and laboratory medicine 2017; (55(7)):944-948.

    PMID: 27837594
  2. 2

    Novel mutations in patients with hereditary red blood cell membrane disorders using next-generation sequencing.

    He Y, Jia S, Dewan RK, Liao N

    Gene 2017; (627()):556-562 doi:10.1016/j.gene.2017.07.009.

    PMID: 28694211
  3. 3

    Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis.

    Niss O, Chonat S, Dagaonkar N, et al.

    Blood cells, molecules & diseases 2016; (61()):4-9.

    PMID: 27667160
  4. 4

    Red cell ektacytometry in two patients with chronic hemolytic anemia and three new α-spectrin variants.

    Vives-Corrons JL, Krishnevskaya E, Hernández-Rodriguez I, et al.

    Annals of hematology 2022; (101(3)):549-555 doi:10.1007/s00277-021-04723-5.

    PMID: 34845540
  5. 5

    Coinheritance of Hereditary Elliptocytosis and Deletional Hemoglobin H Disease.

    Charoenkwan P, Natesirinilkul R, Choeyprasert W, et al.

    Journal of pediatric hematology/oncology 2017; (39(2)):e69-e70 doi:10.1097/MPH.0000000000000750.

    PMID: 28060122
  6. 6

    A Comprehensive Approach to Neonatal Peripheral Blood Findings of Preterm and Full-term Infants: an Updated Review.

    Zare-Badie Z, Bahmei A, Tamaddon G

    Clinical laboratory 2024; (70(2)) doi:10.7754/Clin.Lab.2023.230428.

    PMID: 38345969
  7. 7

    Clinical and molecular genetic analysis of a Chinese family with hereditary elliptocytosis caused by a novel mutation in the EPB41 gene.

    Cao M, Huang Z, Zhou H, et al.

    Journal of clinical laboratory analysis 2021; (35(6)):e23781 doi:10.1002/jcla.23781.

    PMID: 33942936
  8. 8

    A large family of hereditary spherocytosis and a rare case of hereditary elliptocytosis with a novel SPTA1 mutation underdiagnosed in Taiwan: A case report and literature review.

    Shih YH, Huang YC, Lin CY, et al.

    Medicine 2023; (102(4)):e32708 doi:10.1097/MD.0000000000032708.

    PMID: 36705355
  9. 9

    A novel EPB41 p.Trp704* mutation in a Korean patient with hereditary elliptocytosis: a case report.

    Shin S, Hwang KA, Paik K, Park J

    Hematology (Amsterdam, Netherlands) 2020; (25(1)):321-326 doi:10.1080/16078454.2020.1807227.

    PMID: 32807033
  10. 10

    Hereditary Pyropoikilocytosis as a Modifier of Sickle Cell Disease Severity.

    Lantz M, Dolatshahi L

    Journal of pediatric hematology/oncology 2025; (47(3)):128-130 doi:10.1097/MPH.0000000000003012.

    PMID: 40036694
  11. 11

    A SEVEN-YEAR-OLD MALE WITH CIRCULATING RED BLOOD CELLS SHOWING A THERMAL INJURY-LIKE MORPHOLOGY.

    Shackelford R, Ansari J, Veillon D, et al.

    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 2016; (168(1)):6-7.

    PMID: 26986859
  12. 12

    Diagnostic tool for red blood cell membrane disorders: Assessment of a new generation ektacytometer.

    Da Costa L, Suner L, Galimand J, et al.

    Blood cells, molecules & diseases 2016; (56(1)):9-22.

    PMID: 26603718
  13. 13

    Use of Laser Assisted Optical Rotational Cell Analyzer (LoRRca MaxSis) in the Diagnosis of RBC Membrane Disorders, Enzyme Defects, and Congenital Dyserythropoietic Anemias: A Monocentric Study on 202 Patients.

    Zaninoni A, Fermo E, Vercellati C, et al.

    Frontiers in physiology 2018; (9()):451 doi:10.3389/fphys.2018.00451.

    PMID: 29755372
  14. 14

    Clinical Diagnosis of Red Cell Membrane Disorders: Comparison of Osmotic Gradient Ektacytometry and Eosin Maleimide (EMA) Fluorescence Test for Red Cell Band 3 (AE1, SLC4A1) Content for Clinical Diagnosis.

    Zaidi AU, Buck S, Gadgeel M, et al.

    Frontiers in physiology 2020; (11()):636 doi:10.3389/fphys.2020.00636.

    PMID: 32636758
  15. 15

    Analysis of Hereditary Elliptocytosis with Decreased Binding of Eosin-5-maleimide to Red Blood Cells.

    Suemori S, Wada H, Nakanishi H, et al.

    BioMed research international 2015; (2015()):451861 doi:10.1155/2015/451861.

    PMID: 26557672
  16. 16

    Case report: Whole-exome sequencing for a hereditary elliptocytosis case with an unexpectedly low HbA1c.

    Pang L, Zeng Z, Ding Y, et al.

    Frontiers in medicine 2023; (10()):1301760 doi:10.3389/fmed.2023.1301760.

    PMID: 38148910
  17. 17

    The application of next-generation sequencing technology in congenital haemolytic anaemia: a systematic review and meta-analysis.

    Xie S, Zhong Y

    Clinical and experimental medicine 2025; (25(1)):368 doi:10.1007/s10238-025-01896-5.

    PMID: 41217551
  18. 18

    [Clinical and gene mutation characteristics of patients with hereditary ellipsocytosis: nine cases report and literature review].

    Liu X, Li Y, Zhao X, et al.

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023; (44(4)):316-320 doi:10.3760/cma.j.issn.0253-2727.2023.04.009.

    PMID: 37357001
  19. 19

    Unravelling the genetic and phenotypic heterogeneity of SPTA1 gene variants in Hereditary Elliptocytosis and Hereditary Pyropoikilocytosis patients using next-generation sequencing.

    Anil More T, Kedar P

    Gene 2022; (843()):146796 doi:10.1016/j.gene.2022.146796.

    PMID: 35961434
  20. 20

    A rare case report of hemolysis in a newborn: hereditary elliptocytosis.

    Jiang S, Lu R, Tang J

    Frontiers in pediatrics 2024; (12()):1485318 doi:10.3389/fped.2024.1485318.

    PMID: 39502561
  21. 21

    Trans-acting genetic modifiers of clinical severity in heterozygous β-Thalassemia trait.

    Loh JB, Ross JM, Musallam KM, Kuo KHM

    Annals of hematology 2024; (103(11)):4437-4447 doi:10.1007/s00277-024-06007-0.

    PMID: 39316111

This page explains diagnostic tests for Hereditary Elliptocytosis for educational purposes only. Always consult your hematologist or genetic counselor for accurate interpretation of your specific lab results.

Stay up to date

Get notified when new research about Hereditary elliptocytosis is published.

No spam. Unsubscribe anytime.